{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:40:48Z","timestamp":1785307248526,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002385","name":"Ministry of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>An innovative approach has been introduced for identifying and developing novel potent and safe anti-<jats:italic>Babesia<\/jats:italic> and anti-<jats:italic>Theileria<\/jats:italic> agents for the control of animal piroplasmosis. In the present study, we evaluated the inhibitory effects of Malaria Box (MBox) compounds (<jats:italic>n<\/jats:italic>\u2009=\u20098) against the growth of <jats:italic>Babesia microti<\/jats:italic> in mice and conducted bioinformatics analysis between the selected hits and the currently used antibabesial drugs, with far-reaching implications for potent combinations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A fluorescence assay was used to evaluate the in vivo inhibitory effects of the selected compounds. Bioinformatics analysis was conducted using hierarchical clustering, distance matrix and molecular weight correlation, and PubChem fingerprint. The compounds with in vivo potential efficacy were selected to search for their target in the piroplasm parasites using quantitative PCR (qPCR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Screening the MBox against the in vivo growth of the <jats:italic>B.\u00a0microti<\/jats:italic> parasite enabled the discovery of potent new antipiroplasm drugs, including MMV396693 and MMV665875. Interestingly, statistically significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) downregulation of cysteine protease mRNA levels was observed in MMV665875-treated <jats:italic>Theileria equi <\/jats:italic>in vitro culture in comparison with untreated cultures. MMV396693\/clofazimine and MMV665875\/atovaquone (AV) showed maximum structural similarity (MSS) with each other. The distance matrix results indicate promising antibabesial efficacy of combination therapies consisting of either MMV665875 and AV or MMV396693 and imidocarb dipropionate (ID).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Inhibitory and hematology assay results suggest that MMV396693 and MMV665875 are potent antipiroplasm monotherapies. The structural similarity results indicate that MMV665875 and MMV396693 have a similar mode of action as AV and ID, respectively. Our findings demonstrated that MBox compounds provide a promising lead for the development of new antibabesial therapeutic alternatives.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-022-05430-4","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T12:04:09Z","timestamp":1663589049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Mohamed Abdo","family":"Rizk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanadi B.","family":"Baghdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa Abd El-Salam","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Eltaysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"5430_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpara.2018.11.002","volume":"49","author":"CE Suarez","year":"2019","unstructured":"Suarez CE, Alzan HF, Silva MG, Rathinasamy V, Poole WA, Cooke BM. Unravelling the cellular and molecular pathogenesis of bovine babesiosis: is the sky the limit. Int J Parasitol. 2019;49:183\u201397. https:\/\/doi.org\/10.1016\/j.ijpara.2018.11.002.","journal-title":"Int J Parasitol"},{"key":"5430_CR2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2174\/092986712799828355","volume":"19","author":"J Mosqueda","year":"2012","unstructured":"Mosqueda J, Olvera-Ramirez A, Aguilar Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem. 2012;19:1504\u201318. https:\/\/doi.org\/10.2174\/092986712799828355.","journal-title":"Curr Med Chem"},{"key":"5430_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1292\/jvms.09-0535","volume":"72","author":"SJ Hwang","year":"2010","unstructured":"Hwang SJ, Yamasaki M, Nakamura K, Sasaki N, Murakami M, Wickramasekara Rajapakshage BK, et al. Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro. J Vet Med Sci. 2010;72:765\u201371. https:\/\/doi.org\/10.1292\/jvms.09-0535.","journal-title":"J Vet Med Sci"},{"key":"5430_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.exppara.2017.10.016","volume":"183","author":"M Yamasaki","year":"2017","unstructured":"Yamasaki M, Watanabe N, Idaka N, Yamamori T, Otsuguro K, Uchida N, et al. Intracellular diminazene aceturate content and adenosine incorporation in diminazene aceturate-resistant Babesia gibsoni isolate in vitro. Exp Parasitol. 2017;183:92\u20138. https:\/\/doi.org\/10.1016\/j.exppara.2017.10.016.","journal-title":"Exp Parasitol"},{"key":"5430_CR5","doi-asserted-by":"publisher","first-page":"e1005763","DOI":"10.1371\/journal.ppat.1005763","volume":"12","author":"WC Van Voorhis","year":"2016","unstructured":"Van Voorhis WC, Adams JH, Adelfio R, Ahyong V, Akabas MH, Alano P, et al. Open source drug discovery with the malaria box compound collection for neglected diseases and beyond. PLoS Pathog. 2016;12:e1005763. https:\/\/doi.org\/10.1371\/journal.ppat.1005763.","journal-title":"PLoS Pathog"},{"key":"5430_CR6","doi-asserted-by":"publisher","first-page":"108895","DOI":"10.1016\/j.vetpar.2019.07.003","volume":"274","author":"MA Rizk","year":"2019","unstructured":"Rizk MA, El-Sayed SAE, El-Khodery S, Yokoyama N, Igarashi I. Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: a review. Vet Parasitol. 2019;274:108895. https:\/\/doi.org\/10.1016\/j.vetpar.2019.07.003.","journal-title":"Vet Parasitol"},{"key":"5430_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","volume":"48","author":"TN Bennett","year":"2004","unstructured":"Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, et al. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob Agents Chemother. 2004;48:1807\u201310. https:\/\/doi.org\/10.1128\/AAC.48.5.1807-1810.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"5430_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.idc.2008.03.010","volume":"22","author":"E Vannier","year":"2008","unstructured":"Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin North Am. 2008;22:469-88 viii\u2013ix. https:\/\/doi.org\/10.1016\/j.idc.2008.03.010.","journal-title":"Infect Dis Clin North Am"},{"key":"5430_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13071-017-2007-x","volume":"10","author":"K To\u0142kacz","year":"2017","unstructured":"To\u0142kacz K, Bednarska M, Alsarraf M, Dwu\u017cnik D, Grzybek M, Welc-Fal\u0119ciak R, et al. Prevalence, genetic identity and vertical transmission of Babesia microti in three naturally infected species of vole, Microtus spp. (Cricetidae). Parasit Vector. 2017;10:66. https:\/\/doi.org\/10.1186\/s13071-017-2007-x.","journal-title":"Parasit Vector"},{"key":"5430_CR10","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1038\/s41598-017-13052-5","volume":"7","author":"MA Rizk","year":"2017","unstructured":"Rizk MA, El Sayed SAE, AbouLaila M, Eltaysh R, Yokoyama N, Igarashi I. Performance and consistency of a fluorescence-based high-throughput screening assay for use in Babesia drug screening in mice. Sci Rep. 2017;7:2774. https:\/\/doi.org\/10.1038\/s41598-017-13052-5.","journal-title":"Sci Rep."},{"key":"5430_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2147\/IDR.S159519","volume":"11","author":"MA Rizk","year":"2018","unstructured":"Rizk MA, AbouLaila M, El Sayed SAE, Guswanto A, Yokoyama N, Igarashi I. Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance. Infect Drug Resist. 2018;11:1605\u201315. https:\/\/doi.org\/10.2147\/IDR.S159519.","journal-title":"Infect Drug Resist"},{"key":"5430_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9030173","author":"M AbouLaila","year":"2020","unstructured":"AbouLaila M, El Sayed SAE, Omar MA, Al-Aboody MS, Aziz ARA, Abdel Daim MM, et al. Myrrh oil in vitro inhibitory growth on bovine and equine piroplasm parasites and Babesia microti of Mice. Pathogens. 2020. https:\/\/doi.org\/10.3390\/pathogens9030173.","journal-title":"Pathogens"},{"key":"5430_CR13","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1128\/AAC.05488-11","volume":"56","author":"M Aboulaila","year":"2012","unstructured":"Aboulaila M, Munkhjargal T, Sivakumar T, Ueno A, Nakano Y, Yokoyama M, et al. Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites. Antimicrob Agents Chemother. 2012;56:3196\u2013206. https:\/\/doi.org\/10.1128\/AAC.05488-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"5430_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00436-013-3654-2","volume":"113","author":"AA Salama","year":"2014","unstructured":"Salama AA, AbouLaila M, Terkawi MA, Mousa A, El-Sify A, Allaam M, et al. Inhibitory effect of allicin on the growth of Babesia and Theileria equi parasites. Parasitol Res. 2014;113:275\u201383. https:\/\/doi.org\/10.1007\/s00436-013-3654-2.","journal-title":"Parasitol Res"},{"key":"5430_CR15","first-page":"184","volume":"21","author":"MA Randhawa","year":"2009","unstructured":"Randhawa MA. Calculation of LD50 values from the method of Miller and Tainter, 1944. J Ayub Med Coll Abbottabad. 2009;21:184\u20135.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"5430_CR16","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1186\/s13321-016-0148-0","volume":"8","author":"NM O\u2019Boyle","year":"2016","unstructured":"O\u2019Boyle NM, Sayle RA. Comparing structural fingerprints using a literature based similarity benchmark. J Cheminformatics. 2016;8:2206\u201319.","journal-title":"J Cheminformatics"},{"key":"5430_CR17","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gkr320","volume":"39","author":"TW Backman","year":"2011","unstructured":"Backman TW, Cao Y, Girke T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 2011;39:W486-91. https:\/\/doi.org\/10.1093\/nar\/gkr320.","journal-title":"Nucleic Acids Res"},{"key":"5430_CR18","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/bioinformatics\/btn307","volume":"24","author":"Y Cao","year":"2008","unstructured":"Cao Y, Charisi A, Cheng LC, Jiang T, Girke T. ChemmineR: a compound mining framework for R. Bioinformatics. 2008;24:1733\u201344.","journal-title":"Bioinformatics"},{"key":"5430_CR19","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1371\/journal.pone.0125276","volume":"10","author":"MA Rizk","year":"2015","unstructured":"Rizk MA, El Sayed SA, Terkawi MA, Youssef MA, El Said el Sel S, Elsayed G, et al. Optimization of a fluorescence-based assay for large-scale drug screening against Babesia and Theileria parasites. PLoS ONE. 2015;10:5276. https:\/\/doi.org\/10.1371\/journal.pone.0125276.","journal-title":"PLoS ONE"},{"key":"5430_CR20","doi-asserted-by":"crossref","unstructured":"Rizk MA, El-Sayed SAE-S, Igarashi I. Effects of methanolic extract from turmeric (Curcuma longa) against the in vitro multiplication of several Babesia species and Theileria equi. Parasitologia. 2021;1:188\u201396.\u00a0https:\/\/doi.org\/10.3390\/parasitologia1040020.","DOI":"10.3390\/parasitologia1040020"},{"key":"5430_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.exppara.2015.12.016","volume":"161","author":"MA Omar","year":"2016","unstructured":"Omar MA, Salama A, Elsify A, Rizk MA, Al-Aboody MS, AbouLaila M, et al. Evaluation of in vitro inhibitory effect of enoxacin on Babesia and Theileria parasites. Exp Parasitol. 2016;161:62\u20137. https:\/\/doi.org\/10.1016\/j.exppara.2015.12.016.","journal-title":"Exp Parasitol"},{"key":"5430_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.exppara.2017.06.003","volume":"179","author":"MA Rizk","year":"2017","unstructured":"Rizk MA, El Sayed SAE, AbouLaila M, Yokoyama N, Igarashi I. Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites. Exp Parasitol. 2017;179:43\u20138. https:\/\/doi.org\/10.1016\/j.exppara.2017.06.003.","journal-title":"Exp Parasitol"},{"key":"5430_CR23","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.ttbdis.2022.101904","volume":"13","author":"MA Rizk","year":"2022","unstructured":"Rizk MA, El-Sayed SAE, Eltaysh R, Igarashi I. MMV020275 and MMV020490, promising compounds from malaria box for the treatment of equine piroplasmosis. Ticks Tick Borne Dis. 2022;13:101904. https:\/\/doi.org\/10.1016\/j.ttbdis.2022.101904.","journal-title":"Ticks Tick Borne Dis"},{"key":"5430_CR24","doi-asserted-by":"publisher","first-page":"13888","DOI":"10.1038\/s41598-017-14304-0","volume":"7","author":"B Tuvshintulga","year":"2017","unstructured":"Tuvshintulga B, AbouLaila M, Sivakumar T, Tayebwa DS, Gantuya S, Naranbaatar K, et al. Chemotherapeutic efficacies of a clofazimine and diminazene aceturate combination against piroplasm parasites and their AT-rich DNA-binding activity on Babesia bovis. Sci Rep. 2017;7:13888. https:\/\/doi.org\/10.1038\/s41598-017-14304-0.","journal-title":"Sci Rep"},{"key":"5430_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.vetpar.2007.10.023","volume":"151","author":"CM Kim","year":"2008","unstructured":"Kim CM, Blanco LB, Alhassan A, Iseki H, Yokoyama N, Xuan X, et al. Diagnostic real-time PCR assay for the quantitative detection of Theileria equi from equine blood samples. Vet Parasitol. 2008;151:158\u201363. https:\/\/doi.org\/10.1016\/j.vetpar.2007.10.023.","journal-title":"Vet Parasitol"},{"key":"5430_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJSTD Livak","year":"2001","unstructured":"Livak KJSTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u2206\u2206CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"5430_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13071-019-3296-z","volume":"12","author":"SAE El Sayed","year":"2019","unstructured":"El Sayed SAE, Rizk MA, Yokoyama N, Igarashi I. Evaluation of the in vitro and in vivo inhibitory effect of thymoquinone on piroplasm parasites. Parasit Vector. 2019;12:37. https:\/\/doi.org\/10.1186\/s13071-019-3296-z.","journal-title":"Parasit Vector"},{"key":"5430_CR28","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1371\/journal.pone.0062906","volume":"8","author":"T Spangenberg","year":"2013","unstructured":"Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TN, Willis P. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS ONE. 2013;8:2906. https:\/\/doi.org\/10.1371\/journal.pone.0062906.","journal-title":"PLoS ONE"},{"key":"5430_CR29","doi-asserted-by":"publisher","first-page":"111444","DOI":"10.1016\/j.molbiopara.2021.111444","volume":"247","author":"MA Rizk","year":"2022","unstructured":"Rizk MA, El-Sayed SAE, Eltaysh R, Igarashi I. In vivo antibabesial activity and bioinformatic analysis of compounds derived from the medicines for malaria venture box against Babesia microti. Mol Biochem Parasitol. 2022;247:111444. https:\/\/doi.org\/10.1016\/j.molbiopara.2021.111444.","journal-title":"Mol Biochem Parasitol"},{"key":"5430_CR30","doi-asserted-by":"publisher","first-page":"102431","DOI":"10.1016\/j.parint.2021.102431","volume":"85","author":"MA Rizk","year":"2021","unstructured":"Rizk MA, El-Sayed SAE, Igarashi I. Evaluation of the inhibitory effect of Zingiber officinale rhizome on Babesia and Theileria parasites. Parasitol Int. 2021;85:102431. https:\/\/doi.org\/10.1016\/j.parint.2021.102431.","journal-title":"Parasitol Int"},{"key":"5430_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/infdis\/jiz119","volume":"220","author":"DG Mordue","year":"2019","unstructured":"Mordue DG, Wormser GP. Could the drug tafenoquine revolutionize treatment of Babesia microti Infection? J Infect Dis. 2019;220:442\u20137. https:\/\/doi.org\/10.1093\/infdis\/jiz119.","journal-title":"J Infect Dis"},{"key":"5430_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fphar.2016.00107","volume":"7","author":"SDR Verma","year":"2016","unstructured":"Verma SDR, Pandey KC. Cysteine proteases: modes of activation and future prospects as pharmacological targets. Front Pharmacol. 2016;7:107.","journal-title":"Front Pharmacol"},{"key":"5430_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/1471-2164-13-603","volume":"13","author":"LS Kappmeyer","year":"2012","unstructured":"Kappmeyer LS, Thiagarajan M, Herndon DR, Ramsay JD, Caler E, Djikeng A, et al. Comparative genomic analysis and phylogenetic position of Theileria equi. BMC Genom. 2012;13:603. https:\/\/doi.org\/10.1186\/1471-2164-13-603.","journal-title":"BMC Genom"},{"key":"5430_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.188.4.725","volume":"188","author":"JC Engel","year":"1998","unstructured":"Engel JC, Doyle PS, Hsieh I, McKerrow JH. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J Exp Med. 1998;188:725\u201334. https:\/\/doi.org\/10.1084\/jem.188.4.725.","journal-title":"J Exp Med"},{"key":"5430_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0166-6851(96)02703-x","volume":"81","author":"MM Wasilewski","year":"1996","unstructured":"Wasilewski MM, Lim KC, Phillips J, McKerrow JH. Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol Biochem Parasitol. 1996;81:179\u201389. https:\/\/doi.org\/10.1016\/0166-6851(96)02703-x.","journal-title":"Mol Biochem Parasitol"},{"key":"5430_CR36","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.4049\/jimmunol.166.6.4020","volume":"166","author":"L Das","year":"2001","unstructured":"Das L, Datta N, Bandyopadhyay S, Das PK. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol. 2001;166:4020\u20138. https:\/\/doi.org\/10.4049\/jimmunol.166.6.4020.","journal-title":"J Immunol"},{"key":"5430_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.exppara.2007.04.009","volume":"117","author":"K Okubo","year":"2007","unstructured":"Okubo K, Yokoyama N, Govind Y, Alhassan A, Igarashi I. Babesia bovis: effects of cysteine protease inhibitors on in vitro growth. Exp Parasitol. 2007;117:214\u20137. https:\/\/doi.org\/10.1016\/j.exppara.2007.04.009.","journal-title":"Exp Parasitol"},{"key":"5430_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/1471-2164-15-678","volume":"15","author":"J Yamagishi","year":"2014","unstructured":"Yamagishi J, Wakaguri H, Yokoyama N, Yamashita R, Suzuki Y, Xuan X, et al. The Babesia bovis gene and promoter model: an update from full-length EST analysis. BMC Genom. 2014;15:678. https:\/\/doi.org\/10.1186\/1471-2164-15-678.","journal-title":"BMC Genom"},{"key":"5430_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci5020041","author":"ME Ascencio","year":"2018","unstructured":"Ascencio ME, Florin Christensen M, Mamoun CB, Weir W, Shiels B, Schnittger L. Cysteine proteinase C1A paralog profiles correspond with phylogenetic lineages of pathogenic piroplasmids. Vet Sci. 2018. https:\/\/doi.org\/10.3390\/vetsci5020041.","journal-title":"Vet Sci"},{"key":"5430_CR40","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1128\/CMR.16.4.622-636.2003","volume":"16","author":"AMG Zintl","year":"2003","unstructured":"Zintl AMG, Skerrett HE, Taylor SM, Gray JS. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev. 2003;16:622\u201336.","journal-title":"Clin Microbiol Rev"},{"key":"5430_CR41","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1039\/B409813G","volume":"2","author":"A Bender","year":"2004","unstructured":"Bender A, Glen RC. Molecular similarity: a key technique in molecular informatics. Org Biomol Chem. 2004;2:3204\u201318. https:\/\/doi.org\/10.1039\/B409813G.","journal-title":"Org Biomol Chem"},{"key":"5430_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.drudis.2007.01.011","volume":"12","author":"H Eckert","year":"2007","unstructured":"Eckert H, Bajorath J. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov Today. 2007;12:225\u201333. https:\/\/doi.org\/10.1016\/j.drudis.2007.01.011.","journal-title":"Drug Discov Today"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05430-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05430-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05430-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T12:14:36Z","timestamp":1663589676000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05430-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5430"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05430-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Animal Care and Use Committee and the Biological Safety Committee of Obihiro University of Agriculture and Veterinary Medicine in Hokkaido, Japan, authorized all of the experiments in this work (Approval no. 27-65, and pathogen experiment ID for <i>Babesia microti<\/i>: 201709-05).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}